BioVision, Inc. Press releases
Jul 22, 2020
A simple, sensitive, robust assay for the quantification of carbohydrates even when present in low concentration.
Jul 21, 2020
For the measurement of Sialyltransferase activity using a 96-well plate format
Jun 24, 2020
Sensitive method for monitoring GAPDH activity in various sample types
Jun 18, 2020
To measure Hydroxyurea (HU) concentrations in human serum or plasma.
Jun 17, 2020
For the quantitation of N-Acetylcysteine in biological samples.
May 28, 2020
To monitor total β-Mannosidase activity in various biological samples
May 21, 2020
Sensitive method to detect CD38 activity in a variety of sample types.
May 20, 2020
For conjugating hapten molecules to Activated KLH carrier protein
May 18, 2020
. AbVision, Inc., an innovative biopharmaceutical company, announced today that the Company has developed a biosuperior anti-CD47 therapeutic antibody (AVI-105), powered by its SpeedyAb™ technology platform of therapeutic antibody.
May 06, 2020
AbVision, Inc., an innovative biopharmaceutical company, announced today that the Company has developed a first-in-class COVID-19 vaccine candidate (AVI-205) with an active targeting feature, powered by its patented ImmunoBuster-IITM Active Targeting...